Condition: CIDP - Chronic Inflammatory Demyelinating Polyneuropathy · Sponsor: University of Aarhus
SIDEC - (Subcutaneous Immunoglobulin in De-novo CIDP) ia a study designed as a randomized, parallel study with an open-label extension phase. The aims are to compare the effect of SCIG and IVIG in 60 treatment-naïve CIDP patients, and to detect the lowest effective dosage for maintenance treatment.
This description comes directly from the study's public registry record.
Lars Markvardsen, MD, PhD · +45 20231903 · larsmark@rm.dk
Always discuss trial participation with your own doctor first.
| Department of Neurology, Aalborg University Hospital | Aalborg, Denmark | Not Yet Recruiting |
| Department of Neurology, Aarhus University Hospital | Aarhus C, Denmark | Recruiting |
| Department of Neurology, Rigshospitalet, Copenhagen University Hospital | Copenhagen, Denmark | Not Yet Recruiting |
| Department of Neurology, Odense University Hospital | Odense, Denmark | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04589299